No. As of October 2026, SkinBioTherapeutics PLC (SBTX.L) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. SkinBioTherapeutics PLC does not pass Musaffa's business and financial screening criteria.
SkinBioTherapeutics Plc is a life science company, which focuses on skin health. The company is headquartered in Newcastle Upon Tyne, Northumberland and currently employs 41 full-time employees. The company went IPO on 2017-04-05. The principal activity of the Company is that of research and development focused on harnessing the microbiome for human health, and commercialization of these technologies, as well as the manufacture and sales of dermatological products through acquired entities. Its segments include UK, US, EU, and RoW. Its platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin. The company targets five specific skin healthcare sectors, such as cosmetics skincare, food supplements for the treatment of skin conditions, medical skin care, infection control in both the home and the hospital environment and pharmaceuticals for the prescribed treatment of skin conditions. Its first product, AxisBiotix-Ps, is a food supplement to address the symptoms of mild to moderate psoriasis-a chronic inflammatory condition of the skin.
SkinBioTherapeutics PLC SBTX.L
GBX5.75 GBX0.25 (4.17%) 1D
Last Updated: Oct 14, 12:00 AM·LSE
Pricing for GB stocks is delayed by 24 hours
SBTX.L Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, SkinBioTherapeutics PLC is classified as not halal.
NOT HALAL
SkinBioTherapeutics PLC (SBTX.L) Chart
Fetching Price Chart...
Financial Metrics & Statements of SkinBioTherapeutics PLC (SBTX.L)
FAQ's for SkinBioTherapeutics PLC (SBTX.L)
As of October 2026, SkinBioTherapeutics PLC SBTX.L is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes SkinBioTherapeutics PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in SkinBioTherapeutics PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of SkinBioTherapeutics PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of SkinBioTherapeutics PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of SkinBioTherapeutics PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for SkinBioTherapeutics PLC (SBTX.L)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.